How is a Transforaminal Epidural Steroid Injection (TFESI) performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transforaminal Epidural Steroid Injection (TFESI) Technique

TFESI must be performed under fluoroscopic guidance with specific C-arm angle settings that vary by spinal level to ensure accurate needle placement and minimize radiation exposure. 1, 2

Pre-Procedure Setup

Patient Positioning

  • Place patient prone on a flat radiolucent fluoroscopy table without devices to alter lumbar spine curvature 3
  • Maintain sterile technique throughout the procedure 1

Equipment Preparation

  • C-arm fluoroscope positioned for optimal visualization 1
  • Contrast medium to confirm needle placement and rule out intravascular injection 1, 2
  • Steroid mixed with local anesthetic for injection 4

Fluoroscopic Angle Settings by Level

L4-5 Level

  • Oblique angle: 30° (±5°) - achieved in 71% of cases 3
  • Cephalad/caudal tilt: 0° (neutral ±5°) - achieved in 94% of cases 3

L5-S1 Level

  • Oblique angle: 30° (±5°) - achieved in 72% of cases 3
  • Cephalad tilt: 15° (±5°) - achieved in 62% of cases 3
  • In men: cephalocaudal angle of 11.0° and oblique angle of 25° provides maximal safe triangle area of 18.3 mm² 5
  • In women: cephalocaudal angle of 13.9° and oblique angle of 30° provides maximal safe triangle area of 23.6 mm² 5

S1 Level

  • Oblique angle: 5° (±5°) - achieved in 73% of cases 3
  • Cephalad tilt: 15° (±5°) - achieved in 69% of cases 3
  • Alternative "Scotty dog" oblique approach reduces needle passage time (24.4 seconds vs 47.8 seconds with AP approach) 4

Step-by-Step Needle Insertion

Initial Targeting

  • Adjust C-arm to level-specific angles as outlined above 3
  • Identify the "safe triangle" formed by the exiting nerve root superiorly, the lateral border of the vertebral body medially, and the pedicle above 5
  • Mark skin entry point using fluoroscopic guidance 1

Needle Advancement

  • Insert needle at the predetermined angle toward the superior-anterior aspect of the neural foramen 1, 3
  • Advance needle incrementally with intermittent fluoroscopic confirmation 1
  • Expected needle passage time into foramen: 24-48 seconds depending on approach and patient anatomy 4
  • Critical warning: Obese patients (higher BMI) require significantly longer procedure times 4

Confirmation of Needle Position

  • Obtain AP and lateral fluoroscopic views to confirm needle tip position at the superior-anterior aspect of the foramen 1, 2
  • Mandatory contrast injection to visualize spread pattern and rule out intravascular uptake (occurs in 11-23% of cases) 4, 6
  • If intravascular flow detected, reposition needle before injecting therapeutic substance 1, 6

Therapeutic Injection

Injection Technique

  • After confirming negative intravascular flow, inject steroid mixed with local anesthetic 1, 4
  • Observe contrast spread along nerve root and into epidural space 1
  • Document final needle position and contrast pattern 1

Radiation Safety Considerations

C-Arm Positioning

  • Source-superior position is preferred when working space is required 7
  • Source-superior position delivers approximately 2.3 mSv effective dose per case 7
  • Source-inferior position with 300mm working space delivers 6.8 mSv (nearly 3 times higher) 7
  • Scatter dose to operator remains below 10% of recommended limits for hands, thyroid, and eyes in source-superior position 7

Fluoroscopy Time

  • Average fluoroscopy time: 1.4 minutes per case or 0.33 minutes per screw 7
  • Minimize fluoroscopy time by using predetermined angle settings as starting points 3

Common Adverse Events and Management

Immediate Complications (9.2% incidence)

  • Vasovagal reaction (4.2%): most common immediate adverse event 6
  • Intravascular flow requiring procedure interruption (1.7%): reposition needle and re-confirm with contrast 6

Delayed Complications (20.0% incidence within 24-72 hours)

  • Pain exacerbation (5.0%) 6
  • Injection site soreness (3.9%) 6
  • Headache (3.9%) 6
  • Facial flushing/sweating (1.8%) 6
  • Insomnia (1.6%) 6

Risk Factors for Adverse Events

  • Female gender associated with higher complication rates 6
  • Younger age associated with higher complication rates 6
  • Higher preprocedure pain scores associated with higher complication rates 6
  • Longer fluoroscopy time associated with higher complication rates 6
  • Important note: Trainee involvement does NOT increase complication rates 6

Critical Safety Warnings

Shared decision-making must include specific discussion of potential serious complications including dural puncture, insertion-site infections, sensorimotor deficits, cauda equina syndrome, discitis, epidural granuloma, and retinal complications. 1, 8, 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.